Results for biopharma. Search took 0.05 seconds.
in The Biotech Weblog, on January 1, 2010
...es Bioxalis Medica Inc. at The Biotech Weblog Procyon Biopharma Inc. announced last week the successful acquisition of Bioxalis Medica Inc. (Bioxalis), a ...
in The Biotech Weblog, on January 6, 2009
...h Conference will be hosted by Moffitt Cancer Center with David F. Hale, chairman and CEO of Hale BioPharma Ventures LLC as the keynote speaker.
Topics include:
Government funding programs for ...
in The Biotech Weblog, on September 7, 2007
What: BIO Investor Forum 2007
When: October 9-11, 2007
Where: Palace Hotel, San Francisco
The BIO Investor Forum 2007 showcases leading public and private biotechnology companies, from small to mid-cap public growth companies. There will be workshops on the following themes:
Alzhe...
in The Biotech Weblog, on July 11, 2007
... Manufacturesd by a Basque biotechnology company, Progenika Biopharma - BLOODchip® - is a DNA biochip which greatly eliminates the risk of adverse reactions due to incompatibility in blood group...
in The Biotech Weblog, on October 23, 2006
For the 5th time in a row, Genentech, Inc, of San Francisco, CA, has topped Science's survey of top employers in the biotechnology and pharmaceutical industries . The web-based survey was carried out by Senn-Delaney Culture Diagnostics & Measurement between May 2 and June 4 of this year,...
in The Biotech Weblog, on July 20, 2006
...Morgan Stanley analyst.
Among Morgan Stanley's top picks were:
MedImmune : Products include biopharmaceuticals for infectious diseases, oncology and immunology : Flumist® , Synagis® , Et...
in The Biotech Weblog, on November 9, 2005
...
Third biggest biotech company Serono has held talks with four biopharma giants about a potential $15 billion takeover. Interested parties were: Novartis, GlaxoSmithKline, Sanofi- Aventis a...
in The Biotech Weblog, on September 19, 2005
...ed underwritten public offering of common stock amounting to 4,000,000 primary shares. Renovis is a biopharmaceutical company developing drugs to treat neurological diseases and disorders. The most ad...
in The Biotech Weblog, on September 14, 2005
What: IMPACT CHINA: Pharmaceutical R&D Global Summit
When: September 18 to 21, 2005
Where: Renaissance Shanghai Pudong Hotel - Shanghai, China
Scientific and business leaders in the pharmaceutical industry will discuss the opportunities and challenges ahead in the rapidly developing Chine...
in The Biotech Weblog, on September 13, 2005
Wyeth formally opened its Grange Castle biotech production facility in South County Dublin, Ireland last week. The $2 Billion, 1.2 million square foot campus is one of the largest integrated biotech manufacturing facilities in the world and is expected to produce some of the Company's ...
in The Biotech Weblog, on September 3, 2005
The last few days have seen a lot of IPO announcements:
Sunesis Pharmaceuticals Inc. may offer up to 6 million shares for between $9 and $11 a share. (Source: Reuters ). Sunesis has three anti-cancer drug candidates, one of which is a drug candidate designated as SNS-314, whihc the company ...
in The Biotech Weblog, on July 13, 2005
...
Procyon Biopharma Inc. announced last week the successful acquisition of Bioxalis Medica Inc. (Bioxalis), a Montreal-based biopharmaceutical company engaged in the research and development o...
Page 1
Subscribe
Use the search to look for other interesting posts
| RSS |  See all blog subscribe options |
 What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |
